MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
Sign Up to like & getrecommendations! Published in 2021 at "PLoS Pathogens"
DOI: 10.1371/journal.ppat.1009283
Abstract: The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for… read more here.
Keywords: mev; measles immune; mev stealth; cd46 ... See more keywords